NTx at the Biointerfaces International Conference 2024 (BIC) 2024 We are pleased to announce that NTx will be participating in the BIC from August 20-23 in Switzerland. Our Scientific Advisor, Prof. Molly Stevens, (UK), will be delivering a keynote address on "Designing and Translating Materials for Advanced Therapeutics and Biosensing." Additionally, our CSO, Dr. Jayesh Kulkarni, will present two talks on mRNA Therapeutics. We look forward to contributing to and engaging with the scientific community at BIC 2024. #Biotech #Therapeutics #mRNATherapeutics #Innovation #mRNA #LPN
NanoVation Therapeutics™
Biotechnology Research
Vancouver, British Columbia 6,563 followers
Delivering tomorrow's genetic medicines, TODAY™
About us
NanoVation Therapeutics™ (NTx) develops customized nucleic acid and lipid nanoparticle technologies to empower its partners’ genetic medicines. By enabling the safe and efficacious delivery of nucleic acids to a variety of tissues, NTx’s unique toolbox can rapidly advance therapeutic concepts into clinical reality. NTx is delivering tomorrow's genetic medicines, TODAY™.
- Website
-
http://www.nanovationtx.com
External link for NanoVation Therapeutics™
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Vancouver, British Columbia
- Type
- Privately Held
- Founded
- 2020
- Specialties
- lipid nanoparticles
Locations
-
Primary
2405 Wesbrook Mall
4th Floor
Vancouver, British Columbia V6T 1Z3, CA
Employees at NanoVation Therapeutics™
-
Christian Kastrup
Senior Investigator at Versiti Blood Research Institute; Professor at Medical College of Wisconsin; Affiliate Professor at The University of British…
-
maryam osooly
Research Technician IV at The University of British Columbia
-
Grishma Pawar, Ph.D
Preclinical Scientist at NanoVation Therapeutics | Brain Drug Delivery | Preclinical in vivo Pharmacology | Nucleic acid delivery
-
Anthony T.
Preclinical research scientist/educator/mentor
Updates
-
CRS 2024 Annual Meeting Highlights Last week, the Controlled Release Society (CRS) awarded our CEO, Dominik Witzigmann, PhD, the 2024 CRS Senior Investigator Award. He also delivered an insightful talk on "Gene Delivery and Gene Editing." Special thanks to Amanda Bray, Tara Locantore, and colleagues for bringing together these brilliant minds. We also extend our gratitude to AstraZeneca for co-sponsoring the Workshop on "Therapeutic Genome Editing." Looking forward to the 2025 CRS Annual Meeting in Philadelphia! #CRS2024 #Biotech #Innovation #LNP #GeneDelivery #GeneEditing #RNA #NanoVationTherapeutics
-
🌐 Focus on Science: Revolutionizing medicine We are thrilled to highlight a groundbreaking perspective by our Board Chair, Pieter Cullis, and Phil Felgner, published in #Nature Reviews Drug Discovery. This perspective traces the 60-year journey that led to the development of lipid nanoparticles (LNPs) for the delivery of nucleic acids, a cornerstone of modern gene therapies. LNPs have enabled the success of nucleic acid-based vaccines and therapeutics, including the COVID-19 mRNA vaccines and treatments for genetic diseases like hATTR. The insights from decades of research now offer promising solutions for many forms of genetic medicines, marking the beginning of a new era in medicine. Discover more about this revolution in medicine: https://lnkd.in/d-Pr2wai #GeneTherapy #LipidNanoparticles #RNA #Biotech #Innovation #Science #NanoVationTherapeutics
-
-
🔬 LRD Highlights Our CSO, Jayesh Kulkarni, and Board Chair, Pieter Cullis, attended the Liposome Research Days (#LRD) 2024 in Glasgow, gaining valuable insights into lipid-based delivery systems for small molecules and nucleic acids. Huge thanks to Yvonne Perrie MBE, Theresa (Terry) M Allen, Pieter Cullis, Jade Forestier, Agata Ugorenko, and Hakam Alaqabani for organizing such an impactful event. Excited for future advancements and collaborations. See you at the next LRD! #Biotech #GeneticMedicines #NucleicAcids #LipidNanoparticles #Innovation #NanoVationTherapeutics
-
-
We are thrilled to share the success of our participation in adMare BioInnovations’ event to announce the signature for their new Innovation Center in Vancouver. The event, held on June 28th, was graced by the presence of Brenda Bailey, Minister of Jobs, Economic Development & Innovation, adMare's CEO Gordon McCauley (He/Him), SeraGene's CEO Erika Siren and our VP, Chemistry Marco Ciufolini, marking a significant milestone for Canada’s and BC’s position at the forefront of the life sciences. The continuing support from #adMare has been instrumental to our success, and we were honored to share our experience and milestones during the event. We look forward to the continued collaboration and the exciting developments ahead. Stay tuned for more updates as we continue to innovate and expand! #NanovationTherapeutics #LifeSciences #Innovation #Growth
-
-
🌟 Teamwork Fuels Innovation in Enabling the Genetic Medicine Revolution At NanoVation, our strength lies not just in our leading one-stop-shop IP portfolio to enable genetic medicines, but also in the interdisciplinary and diverse team behind these breakthroughs. Phil Jackson once said, "The strength of the team is each individual member. The strength of each member is the team." This philosophy is at the heart of how we aim to break the nucleic acid delivery barriers. Our team's collaborative spirit and collective strength is essential as we tackle complex challenges in developing safe and effective lipid nanoparticle technologies for a variety of tissues. Together with our partners, we are advancing the frontiers of genetic medicines to enable better treatments for all. Here’s to our NanoVators — the brilliant minds and dedicated spirits driving our success! #Teamwork #NanoVationTherapeutics #Innovation #GeneticMedicines #NucleicAcids #LipidNanoparticles #HealthcareInnovation #genetherapy #RNA
-
-
Spotlight on our NanoVator: Marco Ciufolini: A Pioneer in Synthetic Organic Chemistry Marco Ciufolini, Co-Founder and VP, Chemistry at NTx, has an illustrious career spanning over three decades in academia and pharmaceutical industry. With a BS from Spring Hill College, a PhD from the University of Michigan, and a PostDoc at Yale, Marco has significantly contributed to the development of commercial pharmaceuticals, including Onpattro® and Masitinib®. Now, at NanoVation, he leads our innovative chemistry efforts. 🏆 Achievements Invented D-Lin-KC2-DMA for nucleic acid delivery Developed Masitinib®, now in phase III clinical trials Authored over 160 technical papers and 48 patents 🎵 Beyond the Lab Marco enjoys history, philosophy, and classical music, both orchestral and operatic. He is an avid user of YouTube and supporter of Wikipedia, both of which provide him with ample material to keep him intellectually stimulated. 🔬Fun Fact Marco became interested in chemistry at age 7 and received his first chemistry set at 8. The rest is history... #Chemistry #Pharmaceuticals #Innovation #NanoVationTherapeutics #NanoVators #RNA #Nucleicacid #LNP
-
🌟 Celebrating Excellence at NanoVation Therapeutics! 🌟 We are thrilled to announce that two of our outstanding NanoVators have received the NanoMedicines Innovation Network (NMIN) Advanced Training Certification (ATC) for their exceptional participation in the Network's Highly Qualified Personnel (HQP) program! 🥇 Fariba Saadati – Gold Certification 🥈 Anthony T. – Silver Certification The #NMIN ATC recognizes remarkable engagement in capacity-building activities that go "above and beyond" fostering professionals ready to make a significant impact. Congratulations, Fariba and Anthony! Your achievements highlight the spirit of innovation and excellence at NTx. We are incredibly proud of your accomplishments and look forward to witnessing your continued success. #NanovationTherapeutics #LifeSciences #Innovation
-
-
NTx Celebrates World Blood Donor Day! 🙌 NTx is committed to make a difference. We are proud to support Canadian Blood Services (CBS) as a Partner for Life. We encourage everyone to book an appointment to donate blood at the Oak Street Donor Centre. A big THANK YOU to Maria Gore our amazing coordinator. 🩸Each blood donation can save up to three lives and supports vital medical treatments for those in need. At NTx, partnering with CBS reflects our commitment to preventing, treating, and curing diseases. Join us in making a positive impact! A heartfelt thank you to the NanoVators who joined us today. Your participation and support make all the difference! #BloodDonation #Health #CanadianBloodServices #Innovation #Pharmaceuticals #NanoVationTherapeutics #RNA #Nucleicacid #LNP
-
-
Join Our Team at NanoVation Therapeutics! Are you passionate about building and supporting high-performing teams in a dynamic and innovative environment? We are looking for a Senior Manager, People & Culture to join us at NTx. Role: Senior Manager, People & Culture Location: Vancouver, BC Reporting To: CEO Key Responsibilities: 🌟 Lead our people strategy and provide insights to the Leadership Team. 🌟 Develop and implement programs that support our NanoVators and organizational goals. 🌟 Drive team engagement and foster a positive culture. 🌟 Manage professional development, full cycle recruitment, onboarding, and performance management. What We’re Looking For: 🎓 10 years of HR leadership experience, preferably in life sciences. 🎓 Strong leadership, mentoring, and coaching skills. 🎓 Strategic thinker with excellent communication skills. Join us and be part of our mission to innovate and excel in the life sciences industry. Apply now to make a significant impact! Full Details can be found here: https://shorturl.at/8V39H